USP Pharmaceutical Analytical Impurities

(8-[3-Aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione)

(tert-butyl N-(1-nitrosopiperidin-4-yl)carbamate)

(7-(2-Butyn-1-yl)-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-(3-piperidinylamino)-3,7-dihydro-1H-purine-2,6-dione)

(8-Bromo-3,9-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione)

(8-Cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride (1:1))

((E)-tert-Butyl 4-(6-((8-cyclopentyl-6-(2-ethoxyvinyl)-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate)

(4-[(5,6-Diphenyl-2-pyrazinyl)amino]-1-butanol)

(2-(4-((5,6-diphenylpyrazin-2-yl)amino)butoxy)acetic acid)

(N-[(3R,4R)-1,4-Dimethylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine)

((R)-N-Methyl-3-phenoxy-3-phenylpropan-1-amine hydrochloride)

(2-((2-Aminophenyl)amino)-5-methylthiophene-3-carbonitrile)

(4-(2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazine-1-carbaldehyde)

(2-[4-(2-Methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid)